Status:
UNKNOWN
Hemolung RAS Registry Program
Lead Sponsor:
Alung Technologies
Conditions:
Acute Hypercapnic Respiratory Failure
Eligibility:
All Genders
18-99 years
Brief Summary
The purpose of the Hemolung RAS Registry Program is to collect retrospective, de-identified, standard of care data following the commercial use of the Hemolung RAS.
Detailed Description
ALung's post-market Hemolung RAS Registry Program provides a continuum for measuring the Hemolung RAS effectiveness and safety in a real-world setting beyond the results reported in pre-market clinica...
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
April 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2019
Estimated Enrollment :
99 Patients enrolled
Trial Details
Trial ID
NCT01855815
Start Date
April 1 2013
End Date
December 1 2019
Last Update
January 28 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.